In this protocol, Dr. Higgins reviews the pathophysiology, diagnosis, and treatment of hypoxic ischemic encephalopathy (HIE).
FDA approves enmetazobactam for treatment of cUTIs
Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.
How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care
FDA issues Complete Response Letter for cefepime-taniborbactam NDA
The FDA has issued a Complete Response Letter for the New Drug Application of cefepime-taniborbactam, requesting additional chemistry, manufacturing, and controls data.
The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels
Link found between adverse childhood experiences, preeclampsia, and depression
Recent research highlighted the significant correlation between adverse childhood experiences and heightened risks of preeclampsia and depression during pregnancy.
Alabama Supreme Court ruling halts IVF treatment at UAB
Following a landmark decision regarding the status of embryos, the University of Alabama at Birmingham has suspended in vitro fertilization services, sparking concerns over reproductive rights and health care access as experts grapple with the legal aftermath.
2 Commerce Drive Cranbury, NJ 08512